Literature DB >> 25651003

Treatment of generalized granuloma annulare - a systematic review.

J Lukács1, S Schliemann1, P Elsner1.   

Abstract

Granuloma annulare (GA) is a benign inflammatory skin disease. Localized GA is likely to resolve spontaneously, while generalized GA (GGA) is rare and may persist for decades. GGA usually is resistant to a variety of therapeutic modalities and takes a chronic course. The objective of this study was to summarize all reported treatments of generalized granuloma annulare. This is a systematic review based on MEDLINE, Embase and Cochrane Central Register search of articles in English and German and a manual search, between 1980 and 2013, to summarize the treatment of generalized granuloma annulare. Most medical literature on treatment of GGA is limited to individual case reports and small series of patients treated without a control group. Randomized controlled clinical studies are missing. Multiple treatment modalities for GGA were reported including topical and systemic steroids, PUVA, isotretinoin, dapsone, pentoxifylline, hydroxychloroquine, cyclosporine, IFN-γ, potassium iodide, nicotinamide, niacinamide, salicylic acid, dipyridamole, PDT, fumaric acid ester, etanercept, infliximab, adalimumab. While there are numerous case reports of successful treatments in the literature including surgical, medical and phototherapy options, well-designed, randomized, controlled clinical trials are required for an evidence-based treatment of GGA.
© 2015 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2015        PMID: 25651003     DOI: 10.1111/jdv.12976

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

Review 1.  [Granuloma annulare].

Authors:  F Butsch; B Weidenthaler-Barth; E von Stebut
Journal:  Hautarzt       Date:  2015-11       Impact factor: 0.751

Review 2.  [Clinical and histological spectrum of palisaded granulomatous dermatitides : Granuloma annulare, necrobiosis lipoidica, rheumatoid nodules, and necrobiotic xanthogranuloma].

Authors:  B Weidenthaler-Barth
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

3.  Generalized granuloma annulare associated with essential thrombocythemia.

Authors:  Sai P Polineni; Steven Lawyer
Journal:  Clin Case Rep       Date:  2020-03-23

4.  Treatment of generalized granuloma annulare with apremilast: A report of 2 cases.

Authors:  Stacy Blum; David Altman
Journal:  JAAD Case Rep       Date:  2019-10-24

Review 5.  Phototherapy in dermatological maladies (Review).

Authors:  Daciana Elena Branisteanu; Diana Stefania Dirzu; Mihaela Paula Toader; Daniel Constantin Branisteanu; Alin Codrut Nicolescu; Ilarie Brihan; Camelia Margareta Bogdanici; George Branisteanu; Andreea Dimitriu; Nicoleta Anton; Elena Andrese Porumb
Journal:  Exp Ther Med       Date:  2022-02-03       Impact factor: 2.447

Review 6.  Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.

Authors:  Tejas P Joshi; Madeleine Duvic
Journal:  Am J Clin Dermatol       Date:  2021-09-08       Impact factor: 7.403

7.  Resolution of refractory generalized granuloma annulare after treatment with alitretinoin.

Authors:  Jun Hyo Lee; Soyun Cho
Journal:  JAAD Case Rep       Date:  2022-04-14

8.  A Unique Case of Squamous Cell Carcinoma Presenting Within a Lesion of Granuloma Annulare.

Authors:  Morgan L Zabel; Tyler Evans; Adam V Sutton; Matthew Stephany
Journal:  Cureus       Date:  2022-08-10

9.  Adverse Events Leading to Discontinuation of Phototherapy: An Observational Study.

Authors:  Isabel Belinchón; María J Sánchez-Pujol; Alejandro Docampo; Laura Cuesta; Luca Schneller-Pavelescu; Jose M Ramos-Rincón
Journal:  Acta Derm Venereol       Date:  2020-03-18       Impact factor: 3.875

10.  ARE ANTIBIOTICS OF ANY USE IN THE MANAGEMENT OF GRANULOMA ANNULARE IN CHILDREN?

Authors:  Germaine Chia; Leila Ahmed; Peter Oligbu; Louis Odeigah; Godwin Oligbu
Journal:  Afr J Infect Dis       Date:  2019-07-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.